130 related articles for article (PubMed ID: 34688635)
1. KDM5D inhibits the transcriptional activation of FKBP4 by suppressing the expression of E2F1 in colorectal cancer in males.
Liu M; Gao N
Biochem Pharmacol; 2021 Dec; 194():114814. PubMed ID: 34688635
[TBL] [Abstract][Full Text] [Related]
2. KDM5D inhibit epithelial-mesenchymal transition of gastric cancer through demethylation in the promoter of Cul4A in male.
Shen X; Hu K; Cheng G; Xu L; Chen Z; Du P; Zhuang Z
J Cell Biochem; 2019 Aug; 120(8):12247-12258. PubMed ID: 30864186
[TBL] [Abstract][Full Text] [Related]
3. Histone demethylase KDM5D upregulation drives sex differences in colon cancer.
Li J; Lan Z; Liao W; Horner JW; Xu X; Liu J; Yoshihama Y; Jiang S; Shim HS; Slotnik M; LaBella KA; Wu CJ; Dunner K; Hsu WH; Lee R; Khanduri I; Terranova C; Akdemir K; Chakravarti D; Shang X; Spring DJ; Wang YA; DePinho RA
Nature; 2023 Jul; 619(7970):632-639. PubMed ID: 37344599
[TBL] [Abstract][Full Text] [Related]
4. Histone demethylase KDM5D represses the proliferation, migration and invasion of hepatocellular carcinoma through the E2F1/TNNC1 axis.
Li L; Zhu G; Gong C; Hu M; Tan K; Jiang L; Li Y; Zhu X; Xie P; Chen X; Yang X
Antioxid Redox Signal; 2024 Mar; ():. PubMed ID: 38504588
[TBL] [Abstract][Full Text] [Related]
5. ATR inhibition controls aggressive prostate tumors deficient in Y-linked histone demethylase KDM5D.
Komura K; Yoshikawa Y; Shimamura T; Chakraborty G; Gerke TA; Hinohara K; Chadalavada K; Jeong SH; Armenia J; Du SY; Mazzu YZ; Taniguchi K; Ibuki N; Meyer CA; Nanjangud GJ; Inamoto T; Lee GM; Mucci LA; Azuma H; Sweeney CJ; Kantoff PW
J Clin Invest; 2018 Jul; 128(7):2979-2995. PubMed ID: 29863497
[TBL] [Abstract][Full Text] [Related]
6. lncRNA NEAT1 facilitates the progression of colorectal cancer via the KDM5A/Cul4A and Wnt signaling pathway.
Shen X; Ye Z; Wu W; Zhao K; Cheng G; Xu L; Gan L; Wu Y; Yang Z
Int J Oncol; 2021 Jul; 59(1):. PubMed ID: 34109988
[TBL] [Abstract][Full Text] [Related]
7. The Histone Demethylase KDM5D Drives Sex Differences in Colorectal Cancer.
Cancer Discov; 2023 Aug; 13(8):1761. PubMed ID: 37387591
[TBL] [Abstract][Full Text] [Related]
8. Increased Mars2 expression upon microRNA-4661-5p-mediated KDM5D downregulation is correlated with malignant degree of gastric cancer cells.
Gu J; Chu K
Cell Biol Int; 2021 Oct; 45(10):2118-2128. PubMed ID: 34273914
[TBL] [Abstract][Full Text] [Related]
9. METTL14-mediated N6-methyladenosine modification of SOX4 mRNA inhibits tumor metastasis in colorectal cancer.
Chen X; Xu M; Xu X; Zeng K; Liu X; Pan B; Li C; Sun L; Qin J; Xu T; He B; Pan Y; Sun H; Wang S
Mol Cancer; 2020 Jun; 19(1):106. PubMed ID: 32552762
[TBL] [Abstract][Full Text] [Related]
10. Investigation of Histone Lysine-Specific Demethylase 5D KDM5D) Isoform Expression in Prostate Cancer Cell Lines: a System Approach.
Jangravi Z; Najafi M; Shabani M
Iran Biomed J; 2016; 20(2):117-21. PubMed ID: 26728332
[TBL] [Abstract][Full Text] [Related]
11. NFYB-induced high expression of E2F1 contributes to oxaliplatin resistance in colorectal cancer via the enhancement of CHK1 signaling.
Fang Z; Gong C; Yu S; Zhou W; Hassan W; Li H; Wang X; Hu Y; Gu K; Chen X; Hong B; Bao Y; Chen X; Zhang X; Liu H
Cancer Lett; 2018 Feb; 415():58-72. PubMed ID: 29203250
[TBL] [Abstract][Full Text] [Related]
12. E2F1/SP3/STAT6 axis is required for IL-4-induced epithelial-mesenchymal transition of colorectal cancer cells.
Chen J; Gong C; Mao H; Li Z; Fang Z; Chen Q; Lin M; Jiang X; Hu Y; Wang W; Zhang X; Chen X; Li H
Int J Oncol; 2018 Aug; 53(2):567-578. PubMed ID: 29901191
[TBL] [Abstract][Full Text] [Related]
13. Resistance to docetaxel in prostate cancer is associated with androgen receptor activation and loss of KDM5D expression.
Komura K; Jeong SH; Hinohara K; Qu F; Wang X; Hiraki M; Azuma H; Lee GS; Kantoff PW; Sweeney CJ
Proc Natl Acad Sci U S A; 2016 May; 113(22):6259-64. PubMed ID: 27185910
[TBL] [Abstract][Full Text] [Related]
14. PRMT5 functionally associates with EZH2 to promote colorectal cancer progression through epigenetically repressing CDKN2B expression.
Yang L; Ma DW; Cao YP; Li DZ; Zhou X; Feng JF; Bao J
Theranostics; 2021; 11(8):3742-3759. PubMed ID: 33664859
[No Abstract] [Full Text] [Related]
15. NCAPD3 enhances Warburg effect through c-myc and E2F1 and promotes the occurrence and progression of colorectal cancer.
Jing Z; Liu Q; He X; Jia Z; Xu Z; Yang B; Liu P
J Exp Clin Cancer Res; 2022 Jun; 41(1):198. PubMed ID: 35689245
[TBL] [Abstract][Full Text] [Related]
16. TRIM16 overexpression inhibits the metastasis of colorectal cancer through mediating Snail degradation.
Ruan L; Liu W; Yang Y; Chu Z; Yang C; Yang T; Sun J
Exp Cell Res; 2021 Sep; 406(1):112735. PubMed ID: 34265287
[TBL] [Abstract][Full Text] [Related]
17. Circular RNA circITGA7 inhibits colorectal cancer growth and metastasis by modulating the Ras pathway and upregulating transcription of its host gene ITGA7.
Li X; Wang J; Zhang C; Lin C; Zhang J; Zhang W; Zhang W; Lu Y; Zheng L; Li X
J Pathol; 2018 Oct; 246(2):166-179. PubMed ID: 29943828
[TBL] [Abstract][Full Text] [Related]
18. JARID1B promotes colorectal cancer proliferation and Wnt/β-catenin signaling via decreasing CDX2 level.
Huang D; Xiao F; Hao H; Hua F; Luo Z; Huang Z; Li Q; Chen S; Cheng X; Zhang X; Fang W; Hu X; Liu F
Cell Commun Signal; 2020 Oct; 18(1):169. PubMed ID: 33109187
[TBL] [Abstract][Full Text] [Related]
19. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
[TBL] [Abstract][Full Text] [Related]
20. Deltex E3 ubiquitin ligase 3 inhibits colorectal cancer cell growth and regulates cell cycle progression via upregulating E2F transcription factor 1.
Xu H; Liang S; Hu J; Liu W; Dong Z; Wei S
Mol Biol Rep; 2022 Mar; 49(3):1661-1668. PubMed ID: 35098394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
